Loading…

Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study

There is ongoing debate on whether screening for nonalcoholic fatty liver disease (NAFLD) is worthwhile in high‐risk groups. Because of shared risk factors, NAFLD is highly prevalent in patients with coronary artery disease. We aimed to test the hypothesis that NAFLD screening in patients requiring...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology (Baltimore, Md.) Md.), 2016-03, Vol.63 (3), p.754-763
Main Authors: Wong, Vincent Wai‐Sun, Wong, Grace Lai‐Hung, Yeung, Judy Ching‐Lam, Fung, Chloe Yuk‐Kiu, Chan, Jasmine Ka‐Lei, Chang, Zoe Hoi‐Yi, Kwan, Chelsia Tsz‐Yan, Lam, Hiu‐Wan, Limquiaco, Jenny, Chim, Angel Mei‐Ling, Yu, Cheuk‐Man, Chan, Henry Lik‐Yuen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is ongoing debate on whether screening for nonalcoholic fatty liver disease (NAFLD) is worthwhile in high‐risk groups. Because of shared risk factors, NAFLD is highly prevalent in patients with coronary artery disease. We aimed to test the hypothesis that NAFLD screening in patients requiring coronary angiogram would identify high‐risk patients and predict long‐term clinical outcomes. This was a prospective cohort study. NAFLD screening was performed by abdominal ultrasonography before coronary angiogram in 612 consecutive patients. At baseline, 356 (58.2%) patients had NAFLD. NAFLD patients, compared with those without, were more likely to have >50% stenosis in one or more coronary arteries (84.6% vs. 64.1%; P 
ISSN:0270-9139
1527-3350
DOI:10.1002/hep.28253